Radiotherapy often targets rapidly dividing cells, which are more likely to be in the G2/M phase. By manipulating the G2 phase, it is possible to sensitize cancer cells to radiation. For example, combining radiotherapy with checkpoint inhibitors can prevent cancer cells from repairing radiation-induced DNA damage, thereby enhancing the efficacy of the treatment.
